AMSBIO has announced the launch of a 384-well version of the AlvetexScaffold cell culture plates. 

 

The AlvetexScaffold 3D cell culture plates provide biopharmaceutical companies with a new tool to improve the predictive accuracy, productivity and biological relevance of their cell-based high-throughput testing. The new 384-well plates will be launched by AMSBIO at SLAS 2014 (Booth 1513) in San Diego (19-21st January 2014).

 

A typical application for this new product is in cancer cell cytotoxicity testing. The AlvetexScaffold 384-well plates allow scientists to grow tumor cells in a way that better mimics the way these cells grow in vivo. It is then very simple to test the cytotoxic effect of novel or existing anti-cancer compounds using standard cell health assays such as MTT, XTT, extracellular oxygen consumption and many others. Researchers can then easily retrieve RNA and protein from the drug treated cells to study mechanism of action and look for biomarkers. AlvetexScaffold plates work seamlessly with liquid-handling robotic systems further enhancing the high-throughput potential of your cell-based testing.

 

AlvetexScaffold is also available through AMSBIO in other formats including a 12-well culture plate, 24-well culture plate, 96-well plate, 6-well and 12-well inserts. These formats enable scientists to construct different 3D cell culture models and assays. These include screening of novel drugs / drug combinations on 3D culture and co-culture models, co-culture to study cell-cell or cell-matrix interactions, the growth of cells at the air-liquid interface and the long-term culture of cells.

 

 

Date: December 18, 2013

Source: AMSBIO